1. Home
  2. DYN vs NOG Comparison

DYN vs NOG Comparison

Compare DYN & NOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • NOG
  • Stock Information
  • Founded
  • DYN 1984
  • NOG 2006
  • Country
  • DYN United States
  • NOG United States
  • Employees
  • DYN N/A
  • NOG N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • NOG Oil & Gas Production
  • Sector
  • DYN Health Care
  • NOG Energy
  • Exchange
  • DYN Nasdaq
  • NOG Nasdaq
  • Market Cap
  • DYN 1.9B
  • NOG 2.1B
  • IPO Year
  • DYN 2020
  • NOG N/A
  • Fundamental
  • Price
  • DYN $21.11
  • NOG $21.37
  • Analyst Decision
  • DYN Strong Buy
  • NOG Buy
  • Analyst Count
  • DYN 15
  • NOG 8
  • Target Price
  • DYN $36.53
  • NOG $29.57
  • AVG Volume (30 Days)
  • DYN 3.2M
  • NOG 2.1M
  • Earning Date
  • DYN 11-05-2025
  • NOG 11-06-2025
  • Dividend Yield
  • DYN N/A
  • NOG 8.39%
  • EPS Growth
  • DYN N/A
  • NOG N/A
  • EPS
  • DYN N/A
  • NOG 1.82
  • Revenue
  • DYN N/A
  • NOG $2,050,402,000.00
  • Revenue This Year
  • DYN N/A
  • NOG $18.41
  • Revenue Next Year
  • DYN N/A
  • NOG N/A
  • P/E Ratio
  • DYN N/A
  • NOG $11.79
  • Revenue Growth
  • DYN N/A
  • NOG 2.50
  • 52 Week Low
  • DYN $6.36
  • NOG $19.88
  • 52 Week High
  • DYN $31.32
  • NOG $44.31
  • Technical
  • Relative Strength Index (RSI)
  • DYN 58.23
  • NOG 43.18
  • Support Level
  • DYN $18.20
  • NOG $21.66
  • Resistance Level
  • DYN $21.98
  • NOG $22.47
  • Average True Range (ATR)
  • DYN 1.78
  • NOG 0.86
  • MACD
  • DYN -0.17
  • NOG 0.08
  • Stochastic Oscillator
  • DYN 57.30
  • NOG 38.72

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

About NOG Northern Oil and Gas Inc.

Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).

Share on Social Networks: